Adiponectin and negative mood in healthy premenopausal and postmenopausal women

Hormones and Behavior

Volumn 58, Issue 5, 2010, Pages 699-704

  Adam, Tanja ^a   Schamarek, Imke ^b   Springer, Elizabeth A ^b   Havel, Peter J ^c   Epel, Elissa E ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adiponectin; Adiposity; Catecholamines; Mood; Stress

Indexed keywords

ADIPONECTIN; ADRENALIN; PRASTERONE; STRESS HORMONE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY FAT; BODY MASS; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; DYSTHYMIA; FEMALE; HUMAN; INSULIN RESISTANCE; LIFE STRESS; MOOD CHANGE; NORADRENALIN URINE LEVEL; OBESITY; POSTMENOPAUSE; PREDICTION; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL ASPECT;

ADIPONECTIN; ADULT; AGED; CROSS-SECTIONAL STUDIES; EPINEPHRINE; FEMALE; HEALTH; HUMANS; IRRITABLE MOOD; MIDDLE AGED; NOREPINEPHRINE; POSTMENOPAUSE; PREMENOPAUSE; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 78349310775     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2010.05.006     Document Type: Article

References (49)

1. Adam T.C., Epel E.S. Stress, eating and the reward system. Physiol. Behav. 2007, 91:449-458.
2. Barrett-Connor E., Ferrara A. Dehydroepiandrosterone, dehydroepiandrosterone sulfate, obesity, waist-hip ratio, and noninsulin-dependent diabetes in postmenopausal women: the Rancho Bernardo Study. J. Clin. Endocrinol. Metab. 1996, 81:59-64.
3. Brummett B.H., Barefoot J.C., Siegler I.C., Clapp-Channing N.E., Lytle B.L., Bosworth H.B., Williams R.B., Mark D.B. Characteristics of socially isolated patients with coronary artery disease who are at elevated risk for mortality. Psychosom. Med. 2001, 63:267-272.
4. Brunner E.J., Hemingway H., Walker B.R., Page M., Clarke P., Juneja M., Shipley M.J., Kumari M., Andrew R., Seckl J.R., Papadopoulos A., Checkley S., Rumley A., Lowe G.D., Stansfeld S.A., Marmot M.G. Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study. Circulation 2002, 106:2659-2665.
5. Chrousos G.P. Stress, chronic inflammation, and emotional and physical well-being: concurrent effects and chronic sequelae. J. Allergy Clin. Immunol. 2000, 106:S275-S291.
6. Chrousos G.P. The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes. Int. J. Obes. Relat. Metab. Disord. 2000, 24(Suppl 2):S50-S55.
7. Cohen S., Kamarck T., Mermelstein R. A global measure of perceived stress. J. Health Soc. Behav. 1983, 24:385-396.
8. Cohen S., Tyrrell D.A., Smith A.P. Psychological stress and susceptibility to the common cold. N. Engl. J. Med. 1991, 325:606-612.
9. Comuzzie A.G., Funahashi T., Sonnenberg G., Martin L.J., Jacob H.J., Black A.E., Maas D., Takahashi M., Kihara S., Tanaka S., Matsuzawa Y., Blangero J., Cohen D., Kissebah A. The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J. Clin. Endocrinol. Metab. 2001, 86:4321-4325.
10. Delporte M.L., Funahashi T., Takahashi M., Matsuzawa Y., Brichard S.M. Pre- and post-translational negative effect of beta-adrenoceptor agonists on adiponectin secretion: in vitro and in vivo studies. Biochem. J. 2002, 367:677-685.
11. Fallo F., Scarda A., Sonino N., Paoletta A., Boscaro M., Pagano C., Federspil G., Vettor R. Effect of glucocorticoids on adiponectin: a study in healthy subjects and in Cushing's syndrome. Eur. J. Endocrinol. 2004, 150:339-344.
12. Fantuzzi G. Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol. 2005, 115:911-919. quiz 920.
13. Fasshauer M., Klein J., Neumann S., Eszlinger M., Paschke R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 2002, 290:1084-1089.
14. Fernandez-Real J.M., Lopez-Bermejo A., Casamitjana R., Ricart W. Novel interactions of adiponectin with the endocrine system and inflammatory parameters. J. Clin. Endocrinol. Metab. 2003, 88:2714-2718.
15. Flier J.S. The adipocyte: storage depot or node on the energy information superhighway?. Cell 1995, 80:15-18.
16. Flier J.S. Diabetes. The missing link with obesity?. Nature 2001, 409:292-293.
17. Gavrila A., Chan J.L., Yiannakouris N., Kontogianni M., Miller L.C., Orlova C., Mantzoros C.S. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. J. Clin. Endocrinol. Metab. 2003, 88:4823-4831.
18. Greendale G.A., Unger J.B., Rowe J.W., Seeman T.E. The relation between cortisol excretion and fractures in healthy older people: results from the MacArthur studies-Mac. J. Am. Geriatr. Soc. 1999, 47:799-803.
19. Habib K.E., Gold P.W., Chrousos G.P. Neuroendocrinology of stress. Endocr. Metab. Clin. N. Am. 2001, 30:695-728. vii-viii.
20. Hansen P.A., Han D.H., Nolte L.A., Chen M., Holloszy J.O. DHEA protects against visceral obesity and muscle insulin resistance in rats fed a high-fat diet. Am. J. Physiol. 1997, 273:R1704-R1708.
21. Herrington D.M., Gordon G.B., Achuff S.C., Trejo J.F., Weisman H.F., Kwiterovich P.O., Pearson T.A. Plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate in patients undergoing diagnostic coronary angiography. J. Am. Coll. Cardiol. 1990, 16:862-870.
22. Juhasz-Vedres G., Rozsa E., Dobszay M.B., Kis Z., Wolfling J., Toldi J., Parducz A., Farkas T. Dehydroepiandrosterone sulfate (DHEAS) is neuroprotective when administered either pre- or post-injury in a focal cortical cold lesion model. Endocrinology 2006, 147:683-866.
23. Jurimae J., Jurimae T. Plasma adiponectin concentration in healthy pre- and postmenopausal women: relationship with body composition, bone mineral, and metabolic variables. Am. J. Physiol. Endocrinol. Metab. 2007, 293:E42-E47.
24. Kajita K., Ishizuka T., Mune T., Miura A., Ishizawa M., Kanoh Y., Kawai Y., Natsume Y., Yasuda K. Dehydroepiandrosterone down-regulates the expression of peroxisome proliferator-activated receptor gamma in adipocytes. Endocrinology 2003, 144:253-259.
25. Karbowska J., Kochan Z. Effect of DHEA on endocrine functions of adipose tissue, the involvement of PPAR gamma. Biochem. Pharmacol. 2005, 70:249-257.
26. Kern P.A., Di Gregorio G.B., Lu T., Rassouli N., Ranganathan G. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 2003, 52:1779-1785.
27. Kwon K., Jung S.H., Choi C., Park S.H. Reciprocal association between visceral obesity and adiponectin: in healthy premenopausal women. Int. J. Cardiol. 2005, 101:385-390.
28. Leo R., Di Lorenzo G., Tesauro M., Cola C., Fortuna E., Zanasi M., Troisi A., Siracusano A., Lauro R., Romeo F. Decreased plasma adiponectin concentration in major depression. Neurosci. Lett. 2006, 407:211-213.
29. Lihn A.S., Pedersen S.B., Richelsen B. Adiponectin: action, regulation and association to insulin sensitivity. Obes. Rev. 2005, 6:13-21.
30. Miller K.K., Rosner W., Lee H., Hier J., Sesmilo G., Schoenfeld D., Neubauer G., Klibanski A. Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J. Clin. Endocrinol. Metab. 2004, 89:525-533.
31. Nestler J.E., Barlascini C.O., Clore J.N., Blackard W.G. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men. J. Clin. Endocrinol. Metab. 1988, 66:57-61.
32. Orentreich N., Brind J.L., Rizer R.L., Vogelman J.H. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J. Clin. Endocrinol. Metab. 1984, 59:551-555.
33. Parker L.N. Control of adrenal androgen secretion. Endocrinol. Metab. Clin. North Am. 1991, 20:401-421.
34. Poehls J., Wassel C.L., Harris T.B., Havel P.J., Swarbrick M.M., Cummings S.R., Newman A.B., Satterfield S., Kanaya A.M. Association of adiponectin with mortality in older adults: the Health, Aging, and Body Composition Study. Diabetologia 2009, 52:591-595.
35. Rosmond R. Role of stress in the pathogenesis of the metabolic syndrome. Psychoneuroendocrinology 2005, 30:1-10.
36. Rupp H., Maisch B. Abdominal fat and sympathetic overactivity. From calorie intake to postmenopausal hypertension. Herz 2003, 28:668-673.
37. Schriock E.D., Buffington C.K., Hubert G.D., Kurtz B.R., Kitabchi A.E., Buster J.E., Givens J.R. Divergent correlations of circulating dehydroepiandrosterone sulfate and testosterone with insulin levels and insulin receptor binding. J. Clin. Endocrinol. Metab. 1988, 66:1329-1331.
38. Stefan N., Vozarova B., Funahashi T., Matsuzawa Y., Weyer C., Lindsay R.S., Youngren J.F., Havel P.J., Pratley R.E., Bogardus C., Tataranni P.A. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 2002, 51:1884-1888.
39. Stewart-Brown S. Emotional wellbeing and its relation to health. Physical disease may well result from emotional distress. BMJ 1998, 317:1608-1609.
40. Swarbrick M.M., Havel P.J. Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans. Metab. Syndr. Relat. Disord. 2008, 6:87-102.
41. Tsigos C., Chrousos G.P. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J. Psychosom. Res. 2002, 53:865-871.
42. van Niekerk J.K., Huppert F.A., Herbert J. Salivary cortisol and DHEA: association with measures of cognition and well-being in normal older men, and effects of three months of DHEA supplementation. Psychoneuroendocrinology 2001, 26:591-612.
43. Vitaliano P.P., Scanlan J.M., Zhang J., Savage M.V., Hirsch I.B., Siegler I.C. A path model of chronic stress, the metabolic syndrome, and coronary heart disease. Psychosom. Med. 2002, 64:418-435.
44. Watson D., Clark L., Tellegen A. Development and validation of breif measure of positive and negative affect: the PANAS scales. J. Pers. Soc. Psychol. 1988, 54:1063-1070.
45. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., Tataranni P.A. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 2001, 86:1930-1935.
46. Williams D.P., Boyden T.W., Pamenter R.W., Lohman T.G., Going S.B. Relationship of body fat percentage and fat distribution with dehydroepiandrosterone sulfate in premenopausal females. J. Clin. Endocrinol. Metab. 1993, 77:80-85.
47. Wolf O.T., Kirschbaum C. Actions of dehydroepiandrosterone and its sulfate in the central nervous system: effects on cognition and emotion in animals and humans. Brain Res. Brain Res. Rev. 1999, 30:264-288.
48. Yamaguchi Y., Tanaka S., Yamakawa T., Kimura M., Ukawa K., Yamada Y., Ishihara M., Sekihara H. Reduced serum dehydroepiandrosterone levels in diabetic patients with hyperinsulinaemia. Clin. Endocrinol. (Oxf.) 1998, 49:377-383.
49. Yilmaz Y. Psychopathology in the context of obesity: the adiponectin hypothesis. Med. Hypotheses 2008, 70:902-903.